The global Spatial Genomics & Transcriptomics market size is expected to be worth around US$ 390.5 million by 2030, according to a new report by Vision Research Reports.
The global Spatial Genomics & Transcriptomics market size was valued at US$ 163.10 million in 2020 and is anticipated to grow at a CAGR of 11.5% during forecast period 2021 to 2030.
Rapid advances in genomics from human sequencing, tissue sequencing, and single-cell sequencing have resulted in the emergence of spatial genomics and transcriptomics sequencing. The market participants are engaged in solidifying their market position through various business strategies considering this market as the lucrative source of revenue in the coming years.
For instance, in May 2020, 10x Genomics introduced its Targeted Gene Expression Solution for single-cell research as well as spatial genomic research. This solution allows researchers to focus on biomarkers and cell types that are important for their studies. The company also initiated shipping of its Visium Spatial Gene Expression Solution in November 2019. Furthermore, the integration of high throughput solutions in omics studies has enabled determining the link between disease occurrence and genome position.
The spatial transcriptomics segment dominated the market with a revenue share of 82.2% in 2020 owing to its high adoption as compared to spatial genomic methods for the transcriptomic study of single cells. The growth of this segment can also be attributed to the availability of automated sequencing methodologies, such as laser capture microdissection technique (LCM), to meet the expanding demand for nucleic acid sequencing of biological specimens or single cells.
Sequencing of a nucleic acid of single cells or specific biological specimens has increased, which has driven the need for automated, robust, and scalable library preparation solutions. Furthermore, an increased understanding of tissue heterogeneity has resulted in the launch of several unique sequencing workflows that are aimed at inferring or preserving the spatial information. This has also accelerated the revenue flow in this segment.
The determination of spatial arrangement of molecules in cells and tissue samples is the basis for biological research and clinical practice and has gained the attention of several entities involved in the field of genetics. Furthermore, advancements in genome perturbation tools, like the CRISPR/Cas9 system, aid the adoption of spatial genomic tools, thereby driving the segment.
The consumables segment dominated the market with a share of 53.0% in 2020 as this segment covers products that are required to run the instruments across various stages of genome mapping from sample preparation to result derivation. High product penetration, wide product availability, frequent purchase of consumables, and increased usage rate of reagents and kits to run the instruments have driven revenue flow in this segment. The development of any new instrument or upgrade of any existing instrument has a direct impact on the segment growth as the development of any new instrument will result in the need for developing the required consumables.
The software segment is anticipated to grow lucratively throughout the forecast period. The increasing volume of ongoing research studies has led to the need for robust software solutions for data management and their interpretation. This is anticipated to drive the segment in the coming years. Furthermore, companies are expanding their service offerings to stay competitive in the space. For instance, in January 2020, Dovetail Genomics expanded its Genome Assembly offerings to include annotations and chromosome-scale assemblies and 3D genome conformation analysis. The company leveraged on its Omni-C Technology to expand its genome assembly services.
The academic customers' segment captured the largest revenue share of 59.3% in 2020. This is because spatial genomic analyses are increasingly being employed in academic research institutions as they provide a comprehensive analysis of various disorders. For instance, the research institute at Children’s Hospital of Philadelphia has installed a Center of Spatial and Functional Genomics to study the genetic basis of several common disorders with the help of 3D Genomics-based techniques.
Spatial genomics and transcriptomics have enabled the researchers of the universities to explore new areas in gene expression dynamics. The technology finds applications in large research projects, such as the Human Cell Atlas, and is useful for academic researchers involved in the study of the morphological state of cells for genetically derived diseases, such as cancer, diabetes, and Alzheimer’s.
The translational research end-use segment held a major share in 2020 as the use of spatial omics technologies in translational research may potentially benefit research by providing a thorough analysis of physiology and state of a disease, which further propels the introduction of new diagnostic tools and therapeutics. Considering these potential benefits, key players are involved in the research and development of predictive and pharmacogenetic tests that help in the early diagnosis of critical disorders.
North America accounted for the largest revenue share of 44.8% in 2020. This is attributed to the strategic investments in disease pathology research and the increased focus on transcriptomics R&D. For instance, the ongoing Single Cell Analysis Program by the National Institutes of Health Common Fund, initiated in 2012, focuses on sequencing approaches and improvement of spatial resolution through fluorescence-based techniques.
S2 Genomics, Inc.
NanoString Technologies, Inc.
Seven Bridges Genomics
Horizon Discovery Group plc
Laser Capture Microdissection (LCM)
FFPE Tissue Samples
Transcriptome In-vivo Analysis (TIVA)
In Situ Sequencing
Microscopy-based RNA Imaging Techniques
Single Molecule RNA Fluorescence In-situ Hybridization (smFISH)
Padlock Probes/ Rolling Circle Amplification
Branched DNA Probes
Microscopy-based Live DNA Imaging
Genome Perturbation Tools
Storage and Management Databases
Middle East and Africa (MEA)
The Spatial Genomics & Transcriptomics market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Spatial Genomics & Transcriptomics market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Spatial Genomics & Transcriptomics market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Spatial Genomics & Transcriptomics market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Spatial Genomics & Transcriptomics market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Spatial Genomics & Transcriptomics capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Spatial Genomics & Transcriptomics by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Spatial Genomics & Transcriptomics market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Spatial Genomics & Transcriptomics market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Spatial Genomics & Transcriptomics market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Spatial Genomics & Transcriptomics industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Spatial Genomics & Transcriptomics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Spatial Genomics & Transcriptomics market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Spatial Genomics & Transcriptomics market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Spatial Genomics & Transcriptomics market. These factors have benefited the growth of the global market for Spatial Genomics & Transcriptomics. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Spatial Genomics & Transcriptomics. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Spatial Genomics & Transcriptomics are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Arrhythmia Monitoring Devices Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030Read more...
Vaginitis Therapeutics Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030Read more...
Botanicals Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030Read more...
Stereotactic Surgery Devices Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...